Tatiana Novobrantseva

Company: NextPoint Therapeutics

Job title: Chief Scientific Officer

Bio:

Dr. Tatiana Novobrantseva is Chief Scientific Officer at NextPoint Therapeutics, leading research in cancer immunotherapy. She previously held senior roles at Moderna and co-founded Verseau Therapeutics. With a Ph.D. in immunology and postdoctoral work at Harvard, she has over 20 patents and 30 scientific publications.

Seminars:

Panel Discussion: From Broad Depletion to Targeted Precision: Minimizing Unintended Immune- Consequences 12:30 pm

Examine challenges and mistakes from the past with myeloid depletion strategies and the consequences of non-specific targeting Explore emerging techniques that allow selective modulation of pathogenic myeloid subsets while preserving protective populations Learn how improved targeting can reduce systemic toxicity and improve therapeutic indexRead more

day: Conference Day Two